Class information for:
Level 1: ANTIOXIDANT PHARMACOL//NITROSONIFEDIPINE//MYOCYTE MIGRATION

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
13109 796 34.9 64%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
708 12194 CALCIUM ANTAGONISTS//AMLODIPINE//ISRADIPINE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ANTIOXIDANT PHARMACOL Address 4 75% 0% 3
2 NITROSONIFEDIPINE Author keyword 4 75% 0% 3
3 MYOCYTE MIGRATION Author keyword 2 67% 0% 2
4 SR 33805 Author keyword 2 67% 0% 2
5 ARTERIAL CA OVERLOAD Author keyword 1 100% 0% 2
6 CARDIOLMEMBRANE BIOPHYS Address 1 100% 0% 2
7 HYPERCHOLESTEROLEMIC HAMSTER Author keyword 1 50% 0% 2
8 NITROSO SPIN TRAP Author keyword 1 100% 0% 2
9 PHYSIOL BIOCHEM SURG Address 1 100% 0% 2
10 RABBIT ARTERIAL WALL Author keyword 1 100% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 NITROSONIFEDIPINE 4 75% 0% 3 Search NITROSONIFEDIPINE Search NITROSONIFEDIPINE
2 MYOCYTE MIGRATION 2 67% 0% 2 Search MYOCYTE+MIGRATION Search MYOCYTE+MIGRATION
3 SR 33805 2 67% 0% 2 Search SR+33805 Search SR+33805
4 ARTERIAL CA OVERLOAD 1 100% 0% 2 Search ARTERIAL+CA+OVERLOAD Search ARTERIAL+CA+OVERLOAD
5 HYPERCHOLESTEROLEMIC HAMSTER 1 50% 0% 2 Search HYPERCHOLESTEROLEMIC+HAMSTER Search HYPERCHOLESTEROLEMIC+HAMSTER
6 NITROSO SPIN TRAP 1 100% 0% 2 Search NITROSO+SPIN+TRAP Search NITROSO+SPIN+TRAP
7 RABBIT ARTERIAL WALL 1 100% 0% 2 Search RABBIT+ARTERIAL+WALL Search RABBIT+ARTERIAL+WALL
8 EXPERIMENTAL ARTERIOSCLEROSIS 1 40% 0% 2 Search EXPERIMENTAL+ARTERIOSCLEROSIS Search EXPERIMENTAL+ARTERIOSCLEROSIS
9 EXPERIMENTAL HYPERCHOLESTEROLEMIA 1 40% 0% 2 Search EXPERIMENTAL+HYPERCHOLESTEROLEMIA Search EXPERIMENTAL+HYPERCHOLESTEROLEMIA
10 ANTIATHEROGENIC EFFECT 1 33% 0% 2 Search ANTIATHEROGENIC+EFFECT Search ANTIATHEROGENIC+EFFECT

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SUPPRESS ATHEROGENESIS 31 92% 2% 12
2 ANGIOGRAPHIC PROGRESSION 16 39% 4% 33
3 ILLUMINATED NIFEDIPINE 6 80% 1% 4
4 AORTIC SUBENDOTHELIUM 4 75% 0% 3
5 ANTAGONIST AMLODIPINE 3 43% 1% 6
6 POTENT CALCIUM ANTAGONIST 3 100% 0% 3
7 CHOLESTEROL FED RABBIT 3 18% 2% 16
8 CA ANTAGONISTS 3 42% 1% 5
9 PROMOTE CHOLESTEROL EFFLUX 2 44% 1% 4
10 PHOTODEGRADATION PRODUCT 2 50% 0% 3

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Novel vascular biology of third-generation L-type calcium channel antagonists - Ancillary actions of amlodipine 2003 90 104 28%
ANTIOXIDANT ACTIVITY OF CALCIUM-CHANNEL BLOCKING-DRUGS 1994 33 18 44%
Antiatherosclerotic effects of calcium channel blockers 2002 20 72 57%
Role of oxidative stress in the development of vascular injury and its therapeutic intervention by nifedipine 2008 26 73 23%
Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy 2004 25 58 29%
CELLULAR PROCESSES IN ATHEROGENESIS - POTENTIAL TARGETS OF CA2+ CHANNEL BLOCKERS 1991 69 115 28%
Anti-Atherosclerotic Potential of Dihydropyridine Calcium Channel Blockers 2012 2 117 34%
Pleiotropic effects of nifedipine on atherosclerosis 2006 17 61 23%
Calcium channel regulation in vascular smooth muscle cells: Synergistic effects of statins and calcium channel blockers 2010 10 53 23%
Nifedipine gastrointestinal therapeutic system: An overview of its antiatherosclerotic effects 2007 3 81 28%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ANTIOXIDANT PHARMACOL 4 75% 0.4% 3
2 CARDIOLMEMBRANE BIOPHYS 1 100% 0.3% 2
3 PHYSIOL BIOCHEM SURG 1 100% 0.3% 2
4 UMR 8604 1 23% 0.4% 3
5 21ST CENTURY COE PROGRAM LIFESTYLE RELATED DIS 1 50% 0.1% 1
6 INTERNAL SURG SCI 1 50% 0.1% 1
7 MED BIOCHEM VASC MED 1 50% 0.1% 1
8 NUTR EPIDEMIOL PREVENT MED 1 50% 0.1% 1
9 PHARMACOL VASC PATHOL 1 50% 0.1% 1
10 STUDIO PREVENZ TER IA VASCULOPATIE ATEROSC 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000161174 CILNIDIPINE//BENIDIPINE//AZELNIDIPINE
2 0.0000155248 LERCANIDIPINE//LACIDIPINE//LERCANIDIPINE HYDROCHLORIDE
3 0.0000150351 ISRADIPINE//CAS 75695 93 1//DENSITY DEPENDENT GROWTH INHIBITION
4 0.0000128279 TRANSGENES CARDIOVASC CONTROL//SILICONE COLLAR//WHHL RABBIT
5 0.0000114455 ELECTRONEGATIVE LDL//ELECTRONEGATIVE LOW DENSITY LIPOPROTEIN//ENZYMATICALLY MODIFIED LDL
6 0.0000109691 AMLODIPINE//DILTIAZEM CR//BESYLATE
7 0.0000106102 PRANIDIPINE//OPC 13340//CAS 99522 79 9
8 0.0000077174 SMOOTHELIN//SMTNL1//SMEMB
9 0.0000072057 AGE RELATED DECREASE IN PGI2 PRODUCTION//EN FACE TECHNIQUE//15 ISOPROSTANE F 2T
10 0.0000062345 PROSTACYCLIN STIMULATING FACTOR//CANINE PLATELET//CELLULAR METABOLITES